Syntara Limited (DUS:UUDA) Financings
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Share purchase plan of new fully paid ordinary shares Closed: A$840,000 raised · A$0.027 a share Use of proceeds: Cash runway to Q3 2027: clinical trial readouts and licensing, Phase 2b MF study preparation, patent suite, offer costs | Jun 10, 2026 | US$589,447 |
| Private placement of new fully paid ordinary shares Announced: A$8M · A$0.027 a share · Canaccord Genuity (Australia) Limited +1 Dealers: Canaccord Genuity (Australia) Limited (co-lead), Euroz Hartleys Limited (co-lead) Use of proceeds: Five clinical trial readouts in 2026, licensing discussions, Phase 2b myelofibrosis study preparation, patent suite and offer costs; runway to Q3 2027 | Apr 29, 2026 | US$5.71M |